Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030

The global drug device combination products market is projected to reach USD 379.17 billion by 2030 from USD 243.02 billion in 2025, at a CAGR of 9.3% during the forecast period.

The rapid expansion of the geriatric demographic, coupled with a notable increase in patients suffering from chronic conditions such as diabetes and cardiovascular diseases, is projected to drive the market for drug-device combination products significantly. Additionally, the steady rise in self-administration practices and a heightened emphasis on patient-centric design and adherence to treatment regimens are expected to further propel market growth. Technological advancements in drug-device combination products, the introduction of innovative products, and favorable reimbursement frameworks, along with supportive government policies, are all anticipated to enhance market dynamics. Furthermore, strategic investments in healthcare infrastructure and initiatives to improve the accessibility and affordability of these combination products will likely contribute significantly to market expansion.

The injectable drug delivery devices segment is expected to grow at the highest CAGR during the forecast period.

In the realm of drug-device combination products, injectable drug delivery systems command the largest market share and are experiencing accelerated growth. This trend is predominantly due to their capacity for rapid, targeted administration of complex biologics and other therapies that are unsuitable for oral delivery routes. The escalating prevalence of chronic diseases, such as diabetes and cancer, is a primary driver of demand in this sector. Additionally, the industry is witnessing a paradigm shift towards self-administration facilitated by user-centered designs, including autoinjectors and pen injectors. Continuous innovation in device technology is enhancing patient comfort, safety, and adherence, further propelling market growth.

The autoinjectors subsegment of the injectable drug delivery devices segment captured the largest market share in 2024.

The injectable drug delivery devices can be subcategorized into prefilled syringes, pen injectors, autoinjectors, needle-free injectors, and wearable injectors. Among these, autoinjectors have experienced a pronounced growth trajectory in the market due to their user-friendly design, convenience, and capability to administer accurate doses of medication. These features make autoinjectors particularly suitable for patients with chronic conditions such as diabetes and multiple sclerosis. The architecture of autoinjectors facilitates self-administration, which enhances patient adherence to treatment regimens and minimizes the necessity for frequent visits to healthcare facilities. Given the rising emphasis on home-based care and patient-centric therapeutic solutions, the market for autoinjectors is poised for significant expansion.

North America accounted for the largest market share in 2024.

The global market for drug-device combination products is categorized into five key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Currently, North America dominates this market due to its substantial burden of chronic diseases, particularly diabetes, which enlarges the patient demographic that relies on these combination products. The region's market growth is further bolstered by the presence of several major industry players and supportive reimbursement policies that facilitate access to innovative therapies. Meanwhile, the Asia Pacific region is projected to experience the highest CAGR during the forecast period, indicating a burgeoning demand and potential for expansion in this sector.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3– 25%
• By Designation: C-level–30%, Director-level–23%, and Other Designations–47%
• By Region: North America–35%, Europe–20%, Asia Pacific–25%, Latin America–13%, and Middle East & Africa–7%

The major players operating in the drug device combination products market are Abbott (US), Boston Scientific Corporation (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AbbVie Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Stryker (US), B. Braun SE (Germany), Terumo Corporation (Japan) and Kaleo, Inc.(US).

Research Coverage

This report studies the drug device combination products market based on product type, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will allow both established companies and new or smaller firms to understand market trends, helping them to increase their market share. Firms that purchase the report can use one or a combination of the strategies mentioned below to enhance their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (increasing prevalence of chronic disease, technological advancements in drug device combination products, new product launches & high R&D investment), restraints (stringent regulatory requirement), opportunities (growth in emerging economies, growing adoption of drug device combination products), challenge (lack of training and awareness, and product malfunction & wastage)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the drug device combination products market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the drug device combination products market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the drug device combination products market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Tables List

Table 1 Drug Device Combination Products Market: Inclusions & Exclusions

Table 2 Exchange Rates Utilized For Conversion To Usd

Table 3 Drug Device Combination Products Market: Study Assumptions

Table 4 Drug Device Combination Products Market: Risk Analysis

Table 5 Diabetes Population Worldwide, 2024 Vs. 2050 (Million)

Table 6 Drug Device Combination Products Market: Porter’s Five Forces

Table 7 Influence Of Key Stakeholders On Buying Process Of Drug Device Combination Products

Table 8 Key Buying Criteria For Drug Device Combination Products

Table 9 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 10 Europe: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 11 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 12 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 13 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 14 Us: Classification And Approval Pathways

Table 15 Us: Classification Of Medical Equipment

Table 16 Us: Time, Cost, And Complexity Of Registration Process

Table 17 Canada: Classification Of Drug Device Combination Products

Table 18 Canada: Risk, Time, Cost, And Complexity Of Registration Process

Table 19 Europe: European Regulatory Framework For

Drug Device Combination Products

Table 20 Europe: Risk, Time, Cost, And Complexity Of Registration Process

Table 21 China: Risk, Time, Cost, And Complexity Of Registration Process

Table 22 Japan: Risk, Time, Cost, And Complexity Of Registration Process

Table 23 Drug Device Combination Products Market: Key Patents Granted, January 2022−april 2025

Table 24 Import Data For Prefilled Syringes (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 25 Export Data For Prefilled Syringes (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 26 Imports Data For Transdermal Patches (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 27 Export Data For Transdermal Patches (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 28 Indicative Pricing Of Drug Device Combination Products,

By Key Player, 2024

Table 29 Average Selling Price Trend Of Injectable Drug Device Delivery Devices, By Key Player, 2022–2024

Table 30 Average Selling Price Trend For Pen Injectors, By Region, 2022–2024

Table 31 Average Selling Price Trend For Inhalers, By Region, 2022–2024

Table 32 Average Selling Price Trend For Drug-eluting Stents,

By Region, 2022–2024

Table 33 Drug Device Combination Products Market: List Of Key Conferences & Events, January 2025–december 2026

Table 34 Drug Device Combination Products Market: Role In Ecosystem

Table 35 Case Study 1: Minimed 780g Diabetes Management System To Combine Continuous Glucose Monitoring With Automated Insulin Delivery

Table 36 Case Study 2: Digiinhaler-smart Inhaler For Asthma/Copd To

Track Lung Function

Table 37 Case Study 3: Adoption Of Pen Injectors By Nemera France To

Improve Therapeutic Outcomes

Table 38 Drug Device Combination Products Market: Reimbursement

Scenario Analysis

Table 39 Drug Device Combination Products Market: Clinical Pipeline Analysis (As Of March 2025)

Table 40 Us-adjusted Reciprocal Tariff Rates

Table 41 Key Product-related Tariff For Drug Device Products

Table 42 Drug Device Combination Products Market, By Product Type,

2023–2030 (Usd Billion)

Table 43 Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 44 Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Country, 2023–2030 (Usd Billion)

Table 45 List Of Key Prefilled Syringes Available In Market

Table 46 Prefilled Syringes Market, By Country, 2023–2030 (Usd Billion)

Table 47 Launch Of Key Glp-1-related Injectables By Major Pharmaceutical Companies, 2010–2024

Table 48 List Of Key Pen Injectors Available In Market

Table 49 Pen Injectors Market, By Country, 2023–2030 (Usd Billion)

Table 50 List Of Key Autoinjectors Available In Market

Table 51 Autoinjectors Market, By Country 2023–2030 (Usd Billion)

Table 52 Top Five Countries With Highest Number Of Diabetes Patients

(20–79 Years), 2021 Vs. 2045 (Million)

Table 53 List Of Key Wereable Injectors Available In Market

Table 54 Wearable Injectors Market, By Country, 2023–2030 (Usd Billion)

Table 55 List Of Key Needle-free Injectors Available In Market

Table 56 Needle-free Injectors Market, By Country 2023–2030 (Usd Billion)

Table 57 Drug Device Combination Products Market For Drug-eluting Stents,

By Country, 2023–2030 (Usd Billion)

Table 58 List Of Key Inhalers Available In Market

Table 59 Drug Device Combination Products Market For Inhalers, By Country, 2023–2030 (Usd Billion)

Table 60 List Of Key Infusion Pumps Available In Market

Table 61 Drug Device Combination Products Market For Infusion Pumps,

By Country, 2023–2030 (Usd Billion)

Table 62 List Of Key Transdermal Patches Available In Market

Table 63 Drug Device Combination Products Market For Transdermal Patches, By Country, 2023–2030 (Usd Billion)

Table 64 List Of Key Drug-coated Balloons Available In Market

Table 65 Drug Device Combination Products Market For Drug-coated Balloons, By Country, 2023–2030 (Usd Billion)

Table 66 Drug Device Combination Products Market For Other Product Types, By Country, 2023–2030 (Usd Billion)

Table 67 Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 68 Drug Device Combination Products Market For Diabetes Management, By Country, 2023–2030 (Usd Billion)

Table 69 Drug Device Combination Products Market For Respiratory Diseases, By Country, 2023–2030 (Usd Billion)

Table 70 Drug Device Combination Products Market For Ophthalmology,

By Country, 2023–2030 (Usd Billion)

Table 71 Drug Device Combination Products Market For Autoimmune Diseases, By Country, 2023–2030 (Usd Billion)

Table 72 Drug Device Combination Products Market For Oncology, By Country, 2023–2030 (Usd Billion)

Table 73 Key Drug Device Combination Products Available For

Infectious Diseases

Table 74 Drug Device Combination Products Market For Infectious Diseases,

By Country, 2023–2030 (Usd Billion)

Table 75 Drug Device Combination Products Market For Cardiovascular Diseases, By Country, 2023–2030 (Usd Billion)

Table 76 Key Drug Device Combination Products Available For

Obesity Management

Table 77 Drug Device Combination Products Market For Obesity Management,

By Country, 2023–2030 (Usd Billion)

Table 78 Key Transdermal Patches Available For Pain Management

Table 79 Drug Device Combination Products Market For Pain Management,

By Country, 2023–2030 (Usd Billion)

Table 80 Drug Device Combination Products Market For Other Applications,

By Country, 2023–2030 (Usd Billion)

Table 81 Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 82 Drug Device Combination Products Market For Hospitals & Clinics,

By Country, 2023–2030 (Usd Billion)

Table 83 Drug Device Combination Products Market For Ambulatory Surgery Centers, By Country, 2023–2030 (Usd Billion)

Table 84 Drug Device Combination Products Market For Long-term Care Facilities, By Country, 2023–2030 (Usd Billion)

Table 85 Drug Device Combination Products Market For Home Care Settings,

By Country, 2023–2030 (Usd Billion)

Table 86 Drug Device Combination Products Market For Other End Users,

By Country, 2023–2030 (Usd Billion)

Table 87 Drug Device Combination Products Market, By Region,

2023–2030 (Usd Billion)

Table 88 Transdermal Patches Market, By Region, 2023–2030 (Thousand Units)

Table 89 Drug-eluting Stents Market, By Region, 2023–2030 (Thousand Units)

Table 90 North America: Drug Device Combination Products Market, By Country, 2023–2030 (Usd Billion)

Table 91 North America: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 92 North America: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 93 North America: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 94 North America: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 95 Us: Key Macroindicators

Table 96 Us: Drug Device Combination Products Market, By Product Type,

2023–2030 (Usd Billion)

Table 97 Us: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 98 Us: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 99 Us: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 100 Canada: Key Macroindicators

Table 101 Canada: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 102 Canada: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 103 Canada: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 104 Canada: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 105 Europe: Drug Device Combination Products Market, By Country,

2023–2030 (Usd Billion)

Table 106 Europe: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 107 Europe: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 108 Europe: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 109 Europe: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 110 Germany: Key Macroindicators

Table 111 Germany: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 112 Germany: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 113 Germany: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 114 Germany: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 115 Uk: Key Macroindicators

Table 116 Uk: Drug Device Combination Products Market, By Product Type,

2023–2030 (Usd Billion)

Table 117 Uk: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 118 Uk: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 119 Uk: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 120 France: Key Macroindicators

Table 121 France: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 122 France: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 123 France: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 124 France: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 125 Italy: Key Macroindicators

Table 126 Italy: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 127 Italy: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 128 Italy: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 129 Italy: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 130 Spain: Key Macroindicators

Table 131 Spain: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 132 Spain: Drug Device Combination Products Market For Injectable

Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 133 Spain: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 134 Spain: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 135 Rest Of Europe: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 136 Rest Of Europe: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 137 Rest Of Europe: Drug Device Combination Products Market, Application, 2023–2030 (Usd Billion)

Table 138 Rest Of Europe: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 139 Asia Pacific: Drug Device Combination Products Market, By Country, 2023–2030 (Usd Billion)

Table 140 Asia Pacific: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 141 Asia Pacific: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 142 Asia Pacific: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 143 Asia Pacific: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 144 China: Key Macroindicators

Table 145 China: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 146 China: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 147 China: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 148 China: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 149 Japan: Key Macroindicators

Table 150 Japan: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 151 Japan: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 152 Japan: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 153 Japan: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 154 India: Key Macroindicators

Table 155 India: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 156 India: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 157 India: Drug Device Combination Products Market, Application,

2023–2030 (Usd Billion)

Table 158 India: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 159 South Korea: Key Macroindicators

Table 160 South Korea: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 161 South Korea: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 162 South Korea: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 163 South Korea: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 164 Australia: Key Macroindicators

Table 165 Australia: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 166 Australia: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 167 Australia: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 168 Australia: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 169 Rest Of Asia Pacific: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 170 Rest Of Asia Pacific: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 171 Rest Of Asia Pacific: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 172 Rest Of Asia Pacific: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 173 Latin America: Drug Device Combination Products Market, By Country, 2023–2030 (Usd Billion)

Table 174 Latin America: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 175 Latin America: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 176 Latin America: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 177 Latin America: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 178 Brazil: Key Macroindicators

Table 179 Brazil: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 180 Brazil: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 181 Brazil: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 182 Brazil: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 183 Mexico: Key Macroindicators

Table 184 Mexico: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 185 Mexico: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 186 Mexico: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 187 Mexico: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 188 Rest Of Latin America: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 189 Rest Of Latin America: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 190 Rest Of Latin America: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 191 Rest Of Latin America: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 192 Middle East & Africa: Drug Device Combination Products Market,

By Region, 2023–2030 (Usd Billion)

Table 193 Middle East & Africa: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 194 Middle East & Africa: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 195 Middle East & Africa: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 196 Middle East & Africa: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 197 Gcc Countries: Drug Device Combination Products Market, By Country, 2023–2030 (Usd Billion)

Table 198 Gcc Countries: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 199 Gcc Countries: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 200 Gcc Countries: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 201 Gcc Countries: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 202 Kingdom Of Saudi Arabia: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 203 Kingdom Of Saudi Arabia: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 204 Kingdom Of Saudi Arabia: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 205 Kingdom Of Saudi Arabia: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 206 Uae: Drug Device Combination Products Market, By Product Type,

2023–2030 (Usd Billion)

Table 207 Uae: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 208 Uae: Drug Device Combination Products Market, By Application,

2023–2030 (Usd Billion)

Table 209 Uae: Drug Device Combination Products Market, By End User,

2023–2030 (Usd Billion)

Table 210 Rest Of Gcc Countries: Drug Device Combination Products Market,

By Product Type, 2023–2030 (Usd Billion)

Table 211 Rest Of Gcc Countries: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2023–2030 (Usd Billion)

Table 212 Rest Of Gcc Countries: Drug Device Combination Products Market,

By Application, 2023–2030 (Usd Billion)

Table 213 Rest Of Gcc Countries: Drug Device Combination Products Market,

By End User, 2023–2030 (Usd Billion)

Table 214 Rest Of Middle East & Africa: Drug Device Combination Products Market, By Product Type, 2023–2030 (Usd Billion)

Table 215 Rest Of Middle East & Africa: Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type,

2023–2030 (Usd Billion)

Table 216 Rest Of Middle East & Africa: Drug Device Combination Products Market, By Application, 2023–2030 (Usd Billion)

Table 217 Rest Of Middle East & Africa: Drug Device Combination Products Market, By End User, 2023–2030 (Usd Billion)

Table 218 Overview Of Strategies Deployed By Key Players In Drug Device Combination Products Market

Table 219 Drug Device Combination Products Market For Autoinjectors:

Degree Of Competition

Table 220 Drug Device Combination Products Market For Pen Injectors:

Degree Of Competition

Table 221 Drug Device Combination Products Market For Transdermal Patches: Degree Of Competition

Table 222 Drug Device Combination Products Market: Region Footprint

Table 223 Drug Device Combination Products Market: Product Type Footprint

Table 224 Drug Device Combination Products Market: Application Footprint

Table 225 Drug Device Combination Products Market: Detailed List Of Key Startups/Sme Players

Table 226 Drug Device Combination Products Market: Competitive Benchmarking Of Key Startups/Sme Players

Table 227 Drug Device Combination Products Market: Product Launches And Approvals, January 2022–march 2025

Table 228 Drug Device Combination Products Market:

Deals, January 2022–march 2025

Table 229 Drug Device Combination Products Market: Expansions, January 2022–march 2025

Table 230 Drug Device Combination Products Market: Other Developments, January 2022–march 2025

Table 231 Abbott: Company Overview

Table 232 Abbott: Products Offered

Table 233 Abbott: Product Launches And Approvals, January 2022–march 2025

Table 234 Abbott: Deals, January 2022–march 2025

Table 235 Eli Lilly And Company: Company Overview

Table 236 Eli Lilly And Company: Products Offered

Table 237 Eli Lilly And Company: Product Approvals, January 2022–march 2025

Table 238 Eli Lilly And Company: Deals, January 2022–march 2025

Table 239 Eli Lilly And Company: Expansions, January 2022–march 2025

Table 240 Eli Lilly And Company: Other Developments, January 2022–march 2025

Table 241 Medtronic: Company Overview

Table 242 Medtronic: Products Offered

Table 243 Medtronic: Product Launches And Approvals,

January 2022–march 2025

Table 244 Medtronic: Deals, January 2022–march 2025

Table 245 Novo Nordisk A/S: Company Overview

Table 246 Novo Nordisk A/S: Products Offered

Table 247 Novo Nordisk A/S: Product Launches And Approvals,

January 2022–march 2025

Table 248 Novo Nordisk A/S: Deals, January 2022–march 2025

Table 249 Novo Nordisk A/S: Expansions, January 2022–march 2025

Table 250 Novartis Ag: Company Overview

Table 251 Novartis Ag: Products Offered

Table 252 Novartis Ag: Product Approvals, January 2022–march 2025

Table 253 Novartis Ag: Deals, January 2022–march 2025

Table 254 Novartis Ag: Expansions, January 2022–march 2025

Table 255 Sanofi: Company Overview

Table 256 Sanofi: Products Offered

Table 257 Sanofi: Product Approvals, January 2022–march 2025

Table 258 Sanofi: Deals, January 2022–march 2025

Table 259 Sanofi: Other Developments, January 2022–march 2025

Table 260 Boston Scientific Corporation: Company Overview

Table 261 Boston Scientific Corporation: Products Offered

Table 262 Boston Scientific Corporation: Product Approvals,

January 2022–march 2025

Table 263 Boston Scientific Corporation: Deals, January 2022–march 2025

Table 264 Becton, Dickinson And Company: Company Overview

Table 265 Becton, Dickinson And Company: Products Offered

Table 266 Becton, Dickinson And Company: Deals, January 2022–march 2025

Table 267 Becton, Dickinson And Company: Other Developments,

January 2022–march 2025

Table 268 Merck Kgaa: Company Overview

Table 269 Merck Kgaa: Products Offered

Table 270 Merck Kgga: Deals, January 2022–march 2025

Table 271 Abbvie Inc.: Company Overview

Table 272 Abbvie Inc.: Products Offered

Table 273 Abbvie Inc: Product Approvals, January 2022–march 2025

Table 274 Abbvie Inc.: Deals, January 2022–march 2025

Table 275 Abbvie Inc.: Expansions, January 2022–march 2025

Table 276 Teva Pharmaceutical Industries Ltd.: Company Overview

Table 277 Teva Pharmaceutical Industries Ltd.: Products Offered

Table 278 Teva Pharmaceutical Industries Ltd.: Product Approvals,

January 2022–march 2025

Table 279 Teva Pharmaceutical Industries Ltd.: Other Developments,

January 2022–march 2025

Table 280 Stryker: Company Overview

Table 281 Stryker: Products Offered

Table 282 B. Braun Se: Company Overview

Table 283 B. Braun Se: Products Offered

Table 284 Terumo Corporation: Company Overview

Table 285 Terumo Corporation: Products Offered

Table 286 Terumo Corporation: Product Launches And Approvals,

January 2022–march 2025

Table 287 Tandem Diabetes Care, Inc.: Company Overview

Table 288 Cequr Simplicity: Company Overview

Table 289 Intarcia Therapeutics, Inc.: Company Overview

Table 290 Halozyme, Inc.: Company Overview

Table 291 Kaleo, Inc.: Company Overview

Table 292 Lead Chemical Co., Ltd.: Company Overview

Table 293 Purdue Pharma L.P.: Company Overview

Table 294 Alvogen: Company Overview

Table 295 Evolutis: Company Overview

Table 296 Mundipharma International Limited: Company Overview

Table 297 Sparsha Pharma International Pvt. Ltd.: Company Overview

Table 298 Supernus Pharmaceuticals, Inc.: Company Overview

Table 299 Alcon Inc.: Company Overview

Figures List

Figure 1 Drug Device Combination Products Market: Segments Considered & Geographical Scope

Figure 2 Drug Device Combination Products Market: Years Considered

Figure 3 Drug Device Combination Products Market: Research Design

Figure 4 Drug Device Combination Products Market: Key Data

From Secondary Sources

Figure 5 Drug Device Combination Products Market: Key Primary Sources

Figure 6 Drug Device Combination Products Market: Insights From Primaries

Figure 7 Drug Device Combination Products Market: Breakdown Of Primaries (By Company Type, Designation, And Region)

Figure 8 Drug Device Combination Products Market: Breakdown Of Primary Interviews (Supply- And Demand-side Participants)

Figure 9 Drug Device Combination Products Market Size Estimation:

Supply-side Analysis (2024)

Figure 10 Pen Injectors Market Size Estimation: Revenue Share Analysis

(Bottom-up Approach)

Figure 11 Autoinjectors Market Size Estimation: Revenue Share Analysis

(Bottom-up Approach)

Figure 12 Drug Device Combination Products Market: Top-down Approach

Figure 13 Drug Device Combination Products Market: Cagr Projections

(Supply Side)

Figure 14 Drug Device Combination Products Market: Data Triangulation

Figure 15 Drug Device Combination Products Market, By Product Type,

2025 Vs. 2030 (Usd Billion)

Figure 16 Drug Device Combination Products Market For Injectable Drug Delivery Devices, By Type, 2025 Vs. 2030 (Usd Billion)

Figure 17 Drug Device Combination Products Market, By Application,

2025 Vs. 2030 (Usd Billion)

Figure 18 Drug Device Combination Products Market, By End User,

2025 Vs. 2030 (Usd Billion)

Figure 19 Regional Snapshot Of Drug Device Combination Products Market

Figure 20 Increasing Number Of Regulatory Approvals And Rising Incidence Of Chronic Diseases To Drive Market

Figure 21 China And Diabetes Management Segment Commanded Largest Market Share In 2024

Figure 22 China To Register Highest Cagr From 2025 To 2030

Figure 23 Drug Device Combination Products Market: Drivers, Restraints, Opportunities, And Challenges

Figure 24 Disability-adjusted Life Years For Individuals With Chronic Obstructive Pulmonary Disease (Copd) In Australia, By Age (2023)

Figure 25 Share Of Global Geriatric Population (Above 60 Years), By Region,

2010 Vs. 2015 Vs. 2030 (Projected)

Figure 26 Drug Device Combination Products Market:

Porter’s Five Forces Analysis

 

Figure 27 Influence Of Key Stakeholders On Buying Process Of Drug Device Combination Products

Figure 28 Key Buying Criteria For Drug Device Combination Products

Figure 29 Drug Device Combination Products Market: Patent Publication Trends And Top Applicant Analysis (January 2014–april 2025)

Figure 30 Top Patent Applicants For Drug Device Combination Products,

By Jurisdiction (January 2014–april 2025)

Figure 31 Drug Device Combination Products Market: Value Chain Analysis

Figure 32 Drug Device Combination Products Market: Adjacent Markets

Figure 33 Drug Device Combination Products Market: Ecosystem Analysis

Figure 34 Drug Device Combination Products Market: Supply Chain Analysis

Figure 35 Drug Device Combination Products Market: Trends/Disruptions Impacting Customers’ Businesses

Figure 36 Drug Device Combination Products Market: Funding And

Number Of Deals, 2019–2023

Figure 37 Drug Device Combination Products Market: Impact Of Ai/Gen Ai

Figure 38 North America: Drug Device Combination Products Market Snapshot

Figure 39 Asia Pacific: Drug Device Combination Products Market Snapshot

Figure 40 Revenue Analysis Of Key Players In Drug Device Combination

Products Market (2020–2024)

Figure 41 Market Share Analysis Of Key Players In Autoinjectors Market (2024)

Figure 42 Market Share Analysis Of Key Players In Pen Injectors Market (2024)

Figure 43 Market Share Analysis Of Key Players In Transdermal

Patches Market (2024)

Figure 44 Ranking Of Key Players In Drug Device Combination

Products Market (2024)

Figure 45 Drug Device Combination Products Market: Company Evaluation Matrix (Key Players), 2024

Figure 46 Drug Device Combination Products Market: Company Footprint

Figure 47 Drug Device Combination Products Market: Company Evaluation Matrix (Startups/Smes), 2024

Figure 48 Ev/Ebitda Of Key Vendors

Figure 49 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 50 Drug Device Combination Products Market: Brand/Product Comparative Analysis

Figure 51 Abbott: Company Snapshot

Figure 52 Eli Lilly And Company: Company Snapshot

Figure 53 Medtronic: Company Snapshot

Figure 54 Novo Nordisk A/S: Company Snapshot

Figure 55 Novartis Ag: Company Snapshot

Figure 56 Sanofi: Company Snapshot

Figure 57 Boston Scientific Corporation: Company Snapshot

Figure 58 Becton, Dickinson And Company: Company Snapshot

Figure 59 Merck Kgaa: Company Snapshot

 

Figure 60 Abbvie Inc.: Company Snapshot

Figure 61 Teva Pharmaceutical Industries Ltd.: Company Snapshot

Figure 62 Stryker: Company Snapshot

Figure 63 B. Braun Se: Company Snapshot

Figure 64 Terumo Corporation: Company Snapshot